As Pfizer INC (PFE) Stock Value Declined, Avalon Advisors LLC Lifted Its Position

May 18, 2018 - By Larry Park

Pfizer Inc. (NYSE:PFE) LogoInvestors sentiment increased to 1.06 in 2017 Q4. Its up 0.10, from 0.96 in 2017Q3. It is positive, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Gateway Invest Advisers Ltd Liability Co reported 0.98% in Pfizer Inc. (NYSE:PFE). Strategic Global Advsrs Lc accumulated 91,800 shares. Murphy Pohlad Asset Mgmt Ltd Liability Corporation reported 1.65% stake. Timber Creek Management Limited Liability Corporation holds 0.75% or 33,328 shares. Burns J W Inc New York holds 0.81% or 88,748 shares. Trust Of Vermont invested 0.91% in Pfizer Inc. (NYSE:PFE). Bruce And Co holds 3.57% of its portfolio in Pfizer Inc. (NYSE:PFE) for 455,332 shares. Country Trust Bank & Trust invested in 925,935 shares or 1.44% of the stock. Moon Cap Mngmt Ltd Company accumulated 5,417 shares. Alpha Windward Limited Liability Company holds 8,985 shares or 0.19% of its portfolio. Noesis Cap Mangement has invested 0.37% in Pfizer Inc. (NYSE:PFE). Canal Insurance holds 2.14% or 166,050 shares. Moreover, Regent Lc has 0.77% invested in Pfizer Inc. (NYSE:PFE) for 64,832 shares. Adirondack Communication stated it has 20,831 shares or 0.55% of all its holdings. 24,519 were accumulated by Birch Hill Ltd Company.

Since December 15, 2017, it had 0 buys, and 13 sales for $17.75 million activity. $249,750 worth of Pfizer Inc. (NYSE:PFE) shares were sold by MACKENZIE ALEXANDER R. 27,323 shares were sold by JOHNSON RADY A, worth $998,666. Another trade for 13,986 shares valued at $501,398 was made by Dolsten Mikael on Friday, March 2. The insider READ IAN C sold 132,312 shares worth $4.76 million. Another trade for 1,758 shares valued at $64,679 was made by CORNWELL W DON on Monday, February 26. Another trade for 33,368 shares valued at $1.24M was sold by SUSMAN SALLY.

Avalon Advisors Llc increased its stake in Pfizer Inc (PFE) by 19.95% based on its latest 2017Q4 regulatory filing with the SEC. Avalon Advisors Llc bought 308,509 shares as the company’s stock declined 3.13% with the market. The hedge fund held 1.85M shares of the health care company at the end of 2017Q4, valued at $67.19 million, up from 1.55 million at the end of the previous reported quarter. Avalon Advisors Llc who had been investing in Pfizer Inc for a number of months, seems to be bullish on the $208.89 billion market cap company. The stock increased 0.08% or $0.03 during the last trading session, reaching $35.71. About 12.35 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since May 18, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Avalon Advisors Llc, which manages about $4.06 billion and $3.26B US Long portfolio, decreased its stake in Berkshire Hathaway Inc (BRKA) by 11 shares to 97 shares, valued at $28.87M in 2017Q4, according to the filing. It also reduced its holding in Boeing Co (NYSE:BA) by 32,175 shares in the quarter, leaving it with 183,233 shares, and cut its stake in Microsoft Corp (NASDAQ:MSFT).

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Investorplace.com which released: “Investors Need to Adopt a Different Mindset for Big Pharma and Biotech Stocks” on May 17, 2018, also Seekingalpha.com with their article: “Pfizer Is A Definite Buy For 2018” published on April 30, 2018, Fool.com published: “Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK)” on May 13, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer: Buy This Dip?” published on May 03, 2018 as well as Streetinsider.com‘s news article titled: “Pfizer (PFE) Announces FDA Approval for Biosimilar RETACRIT” with publication date: May 15, 2018.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

Among 9 analysts covering Pfizer (NYSE:PFE), 3 have Buy rating, 1 Sell and 5 Hold. Therefore 33% are positive. Pfizer had 14 analyst reports since November 21, 2017 according to SRatingsIntel. The stock of Pfizer Inc. (NYSE:PFE) has “Hold” rating given on Sunday, January 28 by SunTrust. The stock has “Hold” rating by Jefferies on Monday, February 26. Jefferies maintained Pfizer Inc. (NYSE:PFE) rating on Friday, April 13. Jefferies has “Hold” rating and $3800 target. The rating was maintained by Leerink Swann with “Market Perform” on Wednesday, January 31. On Wednesday, January 31 the stock rating was maintained by Credit Suisse with “Neutral”. On Wednesday, January 31 the stock rating was maintained by Morgan Stanley with “Overweight”. The stock of Pfizer Inc. (NYSE:PFE) has “Equal-Weight” rating given on Thursday, April 5 by Barclays Capital. BMO Capital Markets maintained it with “Outperform” rating and $42 target in Wednesday, May 2 report. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by BMO Capital Markets on Tuesday, November 21. The rating was maintained by BMO Capital Markets on Friday, December 15 with “Buy”.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: